Table 2. Summary of primary antibodies used in this study.
Antigen | Catalog no. | Immunogen | Host | Vendor | Dilution |
||
---|---|---|---|---|---|---|---|
IB | IHC | IF | |||||
Slc15a1 | LS-C18855 | Synthetic peptide corresponding to human SLC15A1; | Rabbit | Lifespan biosciences | 1:1000 | 1:50 | 1:50 |
sc-20653 | Epitope corresponding to amino acids 366-600 of PEPT1 of human origin | Rabbit | Santa cruz biotechnology | 1:200 | |||
ZO-1 | 61-7300 | Fusion protein corresponding to amino acid residues 463-1109 of human ZO-1 | Rabbit | Zymed/Invitrogen | 1:50 | ||
N-Cadherin | sc-7939 | Amino acid residues 450-512 of human N-cadherin | Rabbit | Santa cruz biotechnology | 1:50 | ||
Actin | sc-1616 | Peptide mapping of C-terminus of human actin | Goat | Santa cruz biotechnology | 1:200 |
IB, immunoblotting; IHC, immunohistochemistry; IF, immunofluorescence.